Delivery Order SPE2DB22D1103-SPE2DB25FTJV7

Award Date 4/7/25
Potential Completion Date 4/8/25
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award, valued at $31,471.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,052.32 contract is for the procurement of 4,562,235,883 units of the medication Trileptal 300 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $9,385.28 and covers the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 16, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, with an ID of SPE2DB20D1100|SPE2DB24FC6A5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRILEPTAL 600 MG TABLET 100S, a medication, with a ceiling value of $3,275.96 and a period of performance through July 9, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the place of performance is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $7,223.90 firm fixed-price delivery order is for the supply of 250 ml bottles of the drug Trileptal, a medication used to treat certain types of seizures. The contract has an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,705.59 Firm Fixed Price Delivery Order, with a completion date of March 1, 2023, is for the supply of 4560094860 - TRILEPTAL 300 MG/5 ML SUSP 250ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,079.45 firm-fixed-price delivery order is for the supply of TRILEPTAL 300 MG/5 ML SUSP 250ML, a pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award, identified as SPE2DB20D3505|SPE2DB24FT2X1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRILEPTAL 300 MG/5 ML SUSP 250ML, a pharmaceutical product, with a ceiling value of $1,785.44 and a completion date of October 26, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $2,853.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles, with a completion date of May 31, 2023. This contract is not designated as a set-aside and is issued as a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, issued by the Defense Logistics Agency (DLA). The contract, valued at $1,607.25, is a Delivery Order with a Firm Fixed Price pricing type. The award covers the delivery of Trileptal, a 300 mg/5 ml suspension medication, with an ultimate completion date of April 8, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTJV7
    Delivery Order

This federal contract award, valued at $16,958.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567829232 TRILEPTAL 300 MG TABLET 100S, with an ultimate completion date of April 8, 2025. The contract is a Delivery Order under a Firm Fixed Price structure, and there is no set-aside designation indicated.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 7/7/25, 1:11 PM